ZYJ-26741-96978
2 vaccinations
2 coded responses
15 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 442 / OH
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Dose 1 — Moderna
-
2021-01-12
Registered in v-safe
-
2021-01-12
Survey response — day 7, dose 1MedDRA: No adverse event — Feeling: Good · Site: Pain · ChillsFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-14
- 2021-01-21
-
2021-01-28
Dose 2 — Moderna
-
2021-01-28
Survey response — day 0, dose 2MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: SweatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-11
- 2021-04-29
- 2021-07-29
- 2022-01-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Moderna | |
| 2 | 2021-01-28 | Moderna |
Free text
Release 1 — day 7, dose 1
Systemic reaction (other): No
Release 2 — day 0, dose 2
Systemic reaction (other): Sweating
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ○ | ○ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release